Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07134907Phase 4Completed
The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH
BPH (Benign Prostatic Hyperplasia)
PrincipalinvestigatorStart date: 2022-07-18

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Beijing Tongren Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shung Lai John Leung, MBBS, FRCSEd, FCSHK, FHKAM

The University of Hong Kong, Hospital Authority

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Qinyang LIU, MBBS, MSc, FRCSEd

Chinese University of Hong Kong

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Clint D. Bahler, MD, MS

Indiana University Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Aria Olumi, MD

Beth Israel Deaconess Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Naeem Bohjani, MD

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Claus Roehrborn, M.D

UT Southwestern, Dallas, TX

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Patrick Keller, PD Dr. med.

LMU University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Alexander P Glaser, MD

Endeavor Health

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Adrian Paz, MD

Medical director

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Mehmet Ilker Gokce, Prof.

Ankara University

Moderately Similar
1 trials

Shared therapeutic areas:

BPH (Benign Prostatic Hyperplasia)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07134907Phase 4PrincipalInvestigator

The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH

BPH (Benign Prostatic Hyperplasia)
Completed

All 1 trials loaded